Growth Capital • Consumer Products

Organigram Invests In Sanity Group

On June 25, 2024, Organigram invested in consumer products company Sanity Group

Investment Context

This is Organigram’s 2nd transaction in the Consumer Products sector.
This is Organigram’s 1st transaction in Germany.

Explore All 560 Growth Capital Consumer Products Deals - Search the Database Free

Investment Summary
Date	June 25, 2024
Target	Sanity Group
Sector	Consumer Products
Investor(s)	Organigram
Deal Type	Growth Capital

Target Company

Sanity Group

Berlin, Germany

Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Organigram

Toronto, Ontario, Canada

Category	Company
Founded	2010
Sector	Consumer Products
Employees	914
Revenue	160M CAD (2024)

DESCRIPTION

Organigram is a producer of cannabis and cannabis-derived products in Canada and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. Organigram was founded in 2010 and is based in Toronto, Ontario.

Deal Context for Investor	#
Overall	3 of 4
Sector: Consumer Products	2 of 3
Type: Growth Capital	1 of 1
Country: Germany	1 of 1
Year: 2024	1 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-12-22	Hyasynth Biologicals Montreal, Quebec, Canada Hyasynth Biologicals is a producer of pure and sustainable products through fermentation. Hyasynth Biologicals was founded in 2014 and is based in Montreal, Quebec.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-12-22

Hyasynth Biologicals

Montreal, Quebec, Canada

Hyasynth Biologicals is a producer of pure and sustainable products through fermentation. Hyasynth Biologicals was founded in 2014 and is based in Montreal, Quebec.

Buy

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2024-12-06	Motif Labs Aylmer, Ontario, Canada Motif Labs is a brand house shaping Canada's cannabis 2.0 market with a portfolio of iconic brands, including BOXHOT (cannabis vape brand), DEBUNK (liquid diamonds vape brand), Rizzlers, and Floe State. Motif Labs was founded in 2017 and is based in Aylmer, Ontario.	Buy	$90M

DATE

TARGET

DEAL TYPE

VALUE

2024-12-06

Motif Labs

Aylmer, Ontario, Canada

Motif Labs is a brand house shaping Canada's cannabis 2.0 market with a portfolio of iconic brands, including BOXHOT (cannabis vape brand), DEBUNK (liquid diamonds vape brand), Rizzlers, and Floe State. Motif Labs was founded in 2017 and is based in Aylmer, Ontario.

Buy

$90M

Explore Related M&A Activity

Consumer Products M&A - Growth Capital M&A Deals - Germany M&A - 2024 M&A